APO Research

APO RESEARCH · REPORT

Quetiapine

Selected research

Market Structure

Global Quetiapine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Quetiapine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Quetiapine include XiaoGan ShenYuan ChemPharm, Teva, Sun Pharmaceutical, Sandoz, Qilu Pharmaceutical, Nanjing Sunlida Biological Technology, Mylan, Lupin and Hetero, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Quetiapine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Quetiapine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Quetiapine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Quetiapine market size, projected growth trends, production technologies, key applications, and end-use industries.

Quetiapine Segment by Company

XiaoGan ShenYuan ChemPharm

Teva

Sun Pharmaceutical

Sandoz

Qilu Pharmaceutical

Nanjing Sunlida Biological Technology

Mylan

Lupin

Hetero

Shanghai Haoyuan Chemexpress

Dr. Reddy's

Aurobindo

AstraZeneca

Wuhan Fortuna Chemical

Waterstone Technology

Toronto Research Chemicals

Nanjing Chemlin Chemical

EMMX Biotechnology

BOC Sciences

AlliChem

Quetiapine Segment by Type

Purity 97%

Purity 98%

Others

Quetiapine Segment by Application

Adult

Aged

Quetiapine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quetiapine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Quetiapine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Quetiapine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Quetiapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Quetiapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Quetiapine Industry Trends Table 2. Quetiapine Industry Drivers Table 3. Quetiapine Industry Opportunities and Challenges Table 4. Quetiapine Industry Restraints Table 5. Global Quetiapine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Quetiapine Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Quetiapine Sales by Manufacturers (kg) & (2021-2026) Table 8. Global Quetiapine Sales Market Share by Manufacturers Table 9. Global Quetiapine Average Sales Price (USD/kg) of Manufacturers (2021-2026) Table 10. Global Quetiapine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Quetiapine Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Quetiapine Manufacturers, Product Type & Application Table 13. Global Quetiapine Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Quetiapine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Purity 97% Table 17. Major Manufacturers of Purity 98% Table 18. Major Manufacturers of Others Table 19. Global Quetiapine Sales by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Quetiapine Sales by Type (2021-2026) & (kg) Table 21. Global Quetiapine Sales by Type (2027-2032) & (kg) Table 22. Global Quetiapine Sales Market Share by Type (2021-2026) Table 23. Global Quetiapine Sales Market Share by Type (2027-2032) Table 24. Global Quetiapine Revenue by Type 2021 VS 2025 VS 2032 (kg) Table 25. Global Quetiapine Revenue by Type (2021-2026) & (kg) Table 26. Global Quetiapine Revenue by Type (2027-2032) & (kg) Table 27. Global Quetiapine Revenue Market Share by Type (2021-2026) Table 28. Global Quetiapine Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Adult Table 30. Major Manufacturers of Aged Table 31. Global Quetiapine Sales by Application 2021 VS 2025 VS 2032 (kg) Table 32. Global Quetiapine Sales by Application (2021-2026) & (kg) Table 33. Global Quetiapine Sales by Application (2027-2032) & (kg) Table 34. Global Quetiapine Sales Market Share by Application (2021-2026) Table 35. Global Quetiapine Sales Market Share by Application (2027-2032) Table 36. Global Quetiapine Revenue by Application 2021 VS 2025 VS 2032 (kg) Table 37. Global Quetiapine Revenue by Application (2021-2026) & (kg) Table 38. Global Quetiapine Revenue by Application (2027-2032) & (kg) Table 39. Global Quetiapine Revenue Market Share by Application (2021-2026) Table 40. Global Quetiapine Revenue Market Share by Application (2027-2032) Table 41. Global Quetiapine Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 42. Global Quetiapine Sales by Region (2021-2026) & (kg) Table 43. Global Quetiapine Sales Market Share by Region (2021-2026) Table 44. Global Quetiapine Sales Forecasted by Region (2027-2032) & (kg) Table 45. Global Quetiapine Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 47. North America Quetiapine Sales by Country (2021-2026) & (kg) Table 48. North America Quetiapine Sales by Country (2027-2032) & (kg) Table 49. Europe Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 50. Europe Quetiapine Sales by Country (2021-2026) & (kg) Table 51. Europe Quetiapine Sales by Country (2027-2032) & (kg) Table 52. Asia Pacific Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 53. Asia Pacific Quetiapine Sales by Country (2021-2026) & (kg) Table 54. Asia Pacific Quetiapine Sales by Country (2027-2032) & (kg) Table 55. South America, Middle East and Africa Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (kg) Table 56. South America, Middle East and Africa Quetiapine Sales by Country (2021-2026) & (kg) Table 57. South America, Middle East and Africa Quetiapine Sales by Country (2027-2032) & (kg) Table 58. Global Quetiapine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Quetiapine Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Quetiapine Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Quetiapine Revenue Market Share by Region (2021-2026) Table 62. Global Quetiapine Revenue Market Share by Region (2027-2032) Table 63. XiaoGan ShenYuan ChemPharm Company Information Table 64. XiaoGan ShenYuan ChemPharm Business Overview Table 65. XiaoGan ShenYuan ChemPharm Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. XiaoGan ShenYuan ChemPharm Quetiapine Product Portfolio Table 67. XiaoGan ShenYuan ChemPharm Recent Development Table 68. Teva Company Information Table 69. Teva Business Overview Table 70. Teva Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Teva Quetiapine Product Portfolio Table 72. Teva Recent Development Table 73. Sun Pharmaceutical Company Information Table 74. Sun Pharmaceutical Business Overview Table 75. Sun Pharmaceutical Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sun Pharmaceutical Quetiapine Product Portfolio Table 77. Sun Pharmaceutical Recent Development Table 78. Sandoz Company Information Table 79. Sandoz Business Overview Table 80. Sandoz Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Sandoz Quetiapine Product Portfolio Table 82. Sandoz Recent Development Table 83. Qilu Pharmaceutical Company Information Table 84. Qilu Pharmaceutical Business Overview Table 85. Qilu Pharmaceutical Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Qilu Pharmaceutical Quetiapine Product Portfolio Table 87. Qilu Pharmaceutical Recent Development Table 88. Nanjing Sunlida Biological Technology Company Information Table 89. Nanjing Sunlida Biological Technology Business Overview Table 90. Nanjing Sunlida Biological Technology Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Nanjing Sunlida Biological Technology Quetiapine Product Portfolio Table 92. Nanjing Sunlida Biological Technology Recent Development Table 93. Mylan Company Information Table 94. Mylan Business Overview Table 95. Mylan Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Mylan Quetiapine Product Portfolio Table 97. Mylan Recent Development Table 98. Lupin Company Information Table 99. Lupin Business Overview Table 100. Lupin Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Lupin Quetiapine Product Portfolio Table 102. Lupin Recent Development Table 103. Hetero Company Information Table 104. Hetero Business Overview Table 105. Hetero Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Hetero Quetiapine Product Portfolio Table 107. Hetero Recent Development Table 108. Shanghai Haoyuan Chemexpress Company Information Table 109. Shanghai Haoyuan Chemexpress Business Overview Table 110. Shanghai Haoyuan Chemexpress Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Shanghai Haoyuan Chemexpress Quetiapine Product Portfolio Table 112. Shanghai Haoyuan Chemexpress Recent Development Table 113. Dr. Reddy's Company Information Table 114. Dr. Reddy's Business Overview Table 115. Dr. Reddy's Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Dr. Reddy's Quetiapine Product Portfolio Table 117. Dr. Reddy's Recent Development Table 118. Aurobindo Company Information Table 119. Aurobindo Business Overview Table 120. Aurobindo Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Aurobindo Quetiapine Product Portfolio Table 122. Aurobindo Recent Development Table 123. AstraZeneca Company Information Table 124. AstraZeneca Business Overview Table 125. AstraZeneca Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. AstraZeneca Quetiapine Product Portfolio Table 127. AstraZeneca Recent Development Table 128. Wuhan Fortuna Chemical Company Information Table 129. Wuhan Fortuna Chemical Business Overview Table 130. Wuhan Fortuna Chemical Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Wuhan Fortuna Chemical Quetiapine Product Portfolio Table 132. Wuhan Fortuna Chemical Recent Development Table 133. Waterstone Technology Company Information Table 134. Waterstone Technology Business Overview Table 135. Waterstone Technology Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Waterstone Technology Quetiapine Product Portfolio Table 137. Waterstone Technology Recent Development Table 138. Toronto Research Chemicals Company Information Table 139. Toronto Research Chemicals Business Overview Table 140. Toronto Research Chemicals Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Toronto Research Chemicals Quetiapine Product Portfolio Table 142. Toronto Research Chemicals Recent Development Table 143. Nanjing Chemlin Chemical Company Information Table 144. Nanjing Chemlin Chemical Business Overview Table 145. Nanjing Chemlin Chemical Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Nanjing Chemlin Chemical Quetiapine Product Portfolio Table 147. Nanjing Chemlin Chemical Recent Development Table 148. EMMX Biotechnology Company Information Table 149. EMMX Biotechnology Business Overview Table 150. EMMX Biotechnology Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. EMMX Biotechnology Quetiapine Product Portfolio Table 152. EMMX Biotechnology Recent Development Table 153. BOC Sciences Company Information Table 154. BOC Sciences Business Overview Table 155. BOC Sciences Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. BOC Sciences Quetiapine Product Portfolio Table 157. BOC Sciences Recent Development Table 158. AlliChem Company Information Table 159. AlliChem Business Overview Table 160. AlliChem Quetiapine Sales (kg), Price (USD/kg), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. AlliChem Quetiapine Product Portfolio Table 162. AlliChem Recent Development Table 163. Key Raw Materials Table 164. Raw Materials Key Suppliers Table 165. Quetiapine Distributors List Table 166. Quetiapine Customers List Table 167. Research Programs/Design for This Report Table 168. Authors List of This Report Table 169. Secondary Sources Table 170. Primary Sources List of Figures Figure 1. Quetiapine Product Image Figure 2. Global Quetiapine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Quetiapine Market Size (2021-2032) & (US$ Million) Figure 4. Global Quetiapine Sales (2021-2032) & (kg) Figure 5. Global Quetiapine Average Price (USD/kg) & (2021-2032) Figure 6. Global Top 5 and 10 Quetiapine Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Purity 97% Image Figure 9. Purity 98% Image Figure 10. Others Image Figure 11. Global Quetiapine Sales by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Quetiapine Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Quetiapine Sales Market Share by Type (2021-2032) Figure 14. Global Quetiapine Revenue by Type (2021 VS 2025 VS 2032) & (kg) Figure 15. Global Quetiapine Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Quetiapine Revenue Market Share by Type (2021-2032) Figure 17. Adult Image Figure 18. Aged Image Figure 19. Global Quetiapine Sales by Application (2021 VS 2025 VS 2032) & (kg) Figure 20. Global Quetiapine Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Quetiapine Sales Market Share by Application (2021-2032) Figure 22. Global Quetiapine Revenue by Application (2021 VS 2025 VS 2032) & (kg) Figure 23. Global Quetiapine Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Quetiapine Revenue Market Share by Application (2021-2032) Figure 25. North America Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 26. North America Quetiapine Sales Market Share by Country (2021-2032) Figure 27. U.S. Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 28. Canada Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 29. Mexico Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 30. Europe Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 31. Europe Quetiapine Sales Market Share by Country (2021-2032) Figure 32. Germany Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 33. France Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 34. U.K. Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 35. Italy Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 36. Netherlands Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 37. Asia Pacific Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 38. Asia Pacific Quetiapine Sales Market Share by Country (2021-2032) Figure 39. China Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 40. Japan Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 41. South Korea Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 42. Southeast Asia Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 43. India Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 44. Australia Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 45. South America, Middle East and Africa Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 46. South America, Middle East and Africa Quetiapine Sales Market Share by Country (2021-2032) Figure 47. Brazil Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 48. South Africa Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 49. Saudi Arabia Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 50. Turkey Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 51. Argentina Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 52. UAE Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 53. Egypt Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 54. Chile Quetiapine Sales and Growth Rate (2021-2032) & (kg) Figure 55. Global Quetiapine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Quetiapine Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Quetiapine Revenue (2021-2032) & (US$ Million) Figure 58. North America Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Quetiapine Revenue (2021-2032) & (US$ Million) Figure 60. Europe Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Quetiapine Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Quetiapine Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Quetiapine Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Quetiapine Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 97%
  • Purity 98%
  • Others
Applications
  • Adult
  • Aged
Companies covered
  • XiaoGan ShenYuan ChemPharm
  • Teva
  • Sun Pharmaceutical
  • Sandoz
  • Qilu Pharmaceutical
  • Nanjing Sunlida Biological Technology
  • Mylan
  • Lupin
  • Hetero
  • Shanghai Haoyuan Chemexpress
  • Dr. Reddy's
  • Aurobindo
  • AstraZeneca
  • Wuhan Fortuna Chemical
  • Waterstone Technology
  • Toronto Research Chemicals
  • Nanjing Chemlin Chemical
  • EMMX Biotechnology
  • BOC Sciences
  • AlliChem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Quetiapine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Quetiapine Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Quetiapine Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Quetiapine Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Quetiapine Market Dynamics
  1. 2.1 Quetiapine Industry Trends
  2. 2.2 Quetiapine Industry Drivers
  3. 2.3 Quetiapine Industry Opportunities and Challenges
  4. 2.4 Quetiapine Industry Restraints
3 Quetiapine Market by Manufacturers
  1. 3.1 Global Quetiapine Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Quetiapine Sales by Manufacturers (2021-2026)
  3. 3.3 Global Quetiapine Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Quetiapine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Quetiapine Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Quetiapine Manufacturers, Product Type & Application
  7. 3.7 Global Quetiapine Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Quetiapine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Quetiapine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Quetiapine Tier 1, Tier 2, and Tier 3
4 Quetiapine Market by Type
  1. 4.1 Quetiapine Type Introduction
  2. 4.1.1 Purity 97%
  3. 4.1.2 Purity 98%
  4. 4.1.3 Others
  5. 4.2 Global Quetiapine Sales by Type
  6. 4.2.1 Global Quetiapine Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Quetiapine Sales by Type (2021-2032)
  8. 4.2.3 Global Quetiapine Sales Market Share by Type (2021-2032)
  9. 4.3 Global Quetiapine Revenue by Type
  10. 4.3.1 Global Quetiapine Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Quetiapine Revenue by Type (2021-2032)
  12. 4.3.3 Global Quetiapine Revenue Market Share by Type (2021-2032)
5 Quetiapine Market by Application
  1. 5.1 Quetiapine Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Aged
  4. 5.2 Global Quetiapine Sales by Application
  5. 5.2.1 Global Quetiapine Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Quetiapine Sales by Application (2021-2032)
  7. 5.2.3 Global Quetiapine Sales Market Share by Application (2021-2032)
  8. 5.3 Global Quetiapine Revenue by Application
  9. 5.3.1 Global Quetiapine Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Quetiapine Revenue by Application (2021-2032)
  11. 5.3.3 Global Quetiapine Revenue Market Share by Application (2021-2032)
6 Global Quetiapine Sales by Region
  1. 6.1 Global Quetiapine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Quetiapine Sales by Region (2021-2032)
  3. 6.2.1 Global Quetiapine Sales by Region (2021-2026)
  4. 6.2.2 Global Quetiapine Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Quetiapine Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Quetiapine Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Quetiapine Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Quetiapine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Quetiapine Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Quetiapine Revenue by Region
  1. 7.1 Global Quetiapine Revenue by Region
  2. 7.1.1 Global Quetiapine Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Quetiapine Revenue by Region (2021-2026)
  4. 7.1.3 Global Quetiapine Revenue by Region (2027-2032)
  5. 7.1.4 Global Quetiapine Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Quetiapine Revenue (2021-2032)
  8. 7.2.2 North America Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Quetiapine Revenue (2021-2032)
  11. 7.3.2 Europe Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Quetiapine Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Quetiapine Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Quetiapine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 XiaoGan ShenYuan ChemPharm
  2. 8.1.1 XiaoGan ShenYuan ChemPharm Company Information
  3. 8.1.2 XiaoGan ShenYuan ChemPharm Business Overview
  4. 8.1.3 XiaoGan ShenYuan ChemPharm Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 XiaoGan ShenYuan ChemPharm Quetiapine Product Portfolio
  6. 8.1.5 XiaoGan ShenYuan ChemPharm Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Quetiapine Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sun Pharmaceutical
  14. 8.3.1 Sun Pharmaceutical Company Information
  15. 8.3.2 Sun Pharmaceutical Business Overview
  16. 8.3.3 Sun Pharmaceutical Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Quetiapine Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Quetiapine Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Qilu Pharmaceutical
  26. 8.5.1 Qilu Pharmaceutical Company Information
  27. 8.5.2 Qilu Pharmaceutical Business Overview
  28. 8.5.3 Qilu Pharmaceutical Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Qilu Pharmaceutical Quetiapine Product Portfolio
  30. 8.5.5 Qilu Pharmaceutical Recent Developments
  31. 8.6 Nanjing Sunlida Biological Technology
  32. 8.6.1 Nanjing Sunlida Biological Technology Company Information
  33. 8.6.2 Nanjing Sunlida Biological Technology Business Overview
  34. 8.6.3 Nanjing Sunlida Biological Technology Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Nanjing Sunlida Biological Technology Quetiapine Product Portfolio
  36. 8.6.5 Nanjing Sunlida Biological Technology Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Quetiapine Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Lupin
  44. 8.8.1 Lupin Company Information
  45. 8.8.2 Lupin Business Overview
  46. 8.8.3 Lupin Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lupin Quetiapine Product Portfolio
  48. 8.8.5 Lupin Recent Developments
  49. 8.9 Hetero
  50. 8.9.1 Hetero Company Information
  51. 8.9.2 Hetero Business Overview
  52. 8.9.3 Hetero Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hetero Quetiapine Product Portfolio
  54. 8.9.5 Hetero Recent Developments
  55. 8.10 Shanghai Haoyuan Chemexpress
  56. 8.10.1 Shanghai Haoyuan Chemexpress Company Information
  57. 8.10.2 Shanghai Haoyuan Chemexpress Business Overview
  58. 8.10.3 Shanghai Haoyuan Chemexpress Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Shanghai Haoyuan Chemexpress Quetiapine Product Portfolio
  60. 8.10.5 Shanghai Haoyuan Chemexpress Recent Developments
  61. 8.11 Dr. Reddy's
  62. 8.11.1 Dr. Reddy's Company Information
  63. 8.11.2 Dr. Reddy's Business Overview
  64. 8.11.3 Dr. Reddy's Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Dr. Reddy's Quetiapine Product Portfolio
  66. 8.11.5 Dr. Reddy's Recent Developments
  67. 8.12 Aurobindo
  68. 8.12.1 Aurobindo Company Information
  69. 8.12.2 Aurobindo Business Overview
  70. 8.12.3 Aurobindo Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Aurobindo Quetiapine Product Portfolio
  72. 8.12.5 Aurobindo Recent Developments
  73. 8.13 AstraZeneca
  74. 8.13.1 AstraZeneca Company Information
  75. 8.13.2 AstraZeneca Business Overview
  76. 8.13.3 AstraZeneca Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AstraZeneca Quetiapine Product Portfolio
  78. 8.13.5 AstraZeneca Recent Developments
  79. 8.14 Wuhan Fortuna Chemical
  80. 8.14.1 Wuhan Fortuna Chemical Company Information
  81. 8.14.2 Wuhan Fortuna Chemical Business Overview
  82. 8.14.3 Wuhan Fortuna Chemical Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Wuhan Fortuna Chemical Quetiapine Product Portfolio
  84. 8.14.5 Wuhan Fortuna Chemical Recent Developments
  85. 8.15 Waterstone Technology
  86. 8.15.1 Waterstone Technology Company Information
  87. 8.15.2 Waterstone Technology Business Overview
  88. 8.15.3 Waterstone Technology Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Waterstone Technology Quetiapine Product Portfolio
  90. 8.15.5 Waterstone Technology Recent Developments
  91. 8.16 Toronto Research Chemicals
  92. 8.16.1 Toronto Research Chemicals Company Information
  93. 8.16.2 Toronto Research Chemicals Business Overview
  94. 8.16.3 Toronto Research Chemicals Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Toronto Research Chemicals Quetiapine Product Portfolio
  96. 8.16.5 Toronto Research Chemicals Recent Developments
  97. 8.17 Nanjing Chemlin Chemical
  98. 8.17.1 Nanjing Chemlin Chemical Company Information
  99. 8.17.2 Nanjing Chemlin Chemical Business Overview
  100. 8.17.3 Nanjing Chemlin Chemical Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Nanjing Chemlin Chemical Quetiapine Product Portfolio
  102. 8.17.5 Nanjing Chemlin Chemical Recent Developments
  103. 8.18 EMMX Biotechnology
  104. 8.18.1 EMMX Biotechnology Company Information
  105. 8.18.2 EMMX Biotechnology Business Overview
  106. 8.18.3 EMMX Biotechnology Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 EMMX Biotechnology Quetiapine Product Portfolio
  108. 8.18.5 EMMX Biotechnology Recent Developments
  109. 8.19 BOC Sciences
  110. 8.19.1 BOC Sciences Company Information
  111. 8.19.2 BOC Sciences Business Overview
  112. 8.19.3 BOC Sciences Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 BOC Sciences Quetiapine Product Portfolio
  114. 8.19.5 BOC Sciences Recent Developments
  115. 8.20 AlliChem
  116. 8.20.1 AlliChem Company Information
  117. 8.20.2 AlliChem Business Overview
  118. 8.20.3 AlliChem Quetiapine Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 AlliChem Quetiapine Product Portfolio
  120. 8.20.5 AlliChem Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Quetiapine Value Chain Analysis
  2. 9.1.1 Quetiapine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Quetiapine Production Mode & Process
  6. 9.2 Quetiapine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Quetiapine Distributors
  9. 9.2.3 Quetiapine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research